We report four cases of Brain Metastases (BM) from non-small cell lung cancer (NSCLC) responding to ZD 1839 therapy after standard therapy failure.

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC)

Soto-Parra, Hector;
2003-01-01

Abstract

We report four cases of Brain Metastases (BM) from non-small cell lung cancer (NSCLC) responding to ZD 1839 therapy after standard therapy failure.
Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Enzyme Inhibitors; Epidermal Growth Factor; Female; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Palliative Care; Quinazolines; Tomography, X-Ray Computed; Treatment Outcome
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0169500203001892-main.pdf

non disponibili

Tipologia: Versione Editoriale (PDF)
Dimensione 269.84 kB
Formato Adobe PDF
269.84 kB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/369789
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 104
  • ???jsp.display-item.citation.isi??? 87
social impact